Synergistic combination of doxorubicin with hydralazine, and disulfiram against MCF-7 breast cancer cell line. Lafi Z, Alshaer W, Gharaibeh L, Alqudah DA, et al. PLoS One 2023;18:e0291981.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lafi Z, Alshaer W, Gharaibeh L, Alqudah DA, et al. Synergistic combination of doxorubicin with hydralazine, and disulfiram against MCF-7 breast cancer cell line. PLoS One 2023;18:e0291981.
PMID: 37768997